GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Capex-to-Operating-Income

Fabino Life Sciences (BOM:543444) Capex-to-Operating-Income : 0.00 (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Fabino Life Sciences's Capital Expenditure for the six months ended in Sep. 2023 was ₹0.00 Mil. Its Operating Income for the six months ended in Sep. 2023 was ₹1.12 Mil.

Hence, Fabino Life Sciences's Capex-to-Operating-Income for the six months ended in Sep. 2023 was 0.00.


Fabino Life Sciences Capex-to-Operating-Income Historical Data

The historical data trend for Fabino Life Sciences's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Capex-to-Operating-Income Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23
Capex-to-Operating-Income
0.03 - 1.98 0.63 0.48

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23
Capex-to-Operating-Income Get a 7-Day Free Trial - - - - -

Competitive Comparison of Fabino Life Sciences's Capex-to-Operating-Income

For the Drug Manufacturers - Specialty & Generic subindustry, Fabino Life Sciences's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fabino Life Sciences's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fabino Life Sciences's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Fabino Life Sciences's Capex-to-Operating-Income falls into.



Fabino Life Sciences Capex-to-Operating-Income Calculation

Fabino Life Sciences's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.067) / 0.139
=0.48

Fabino Life Sciences's Capex-to-Operating-Income for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (0) / 1.119
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fabino Life Sciences  (BOM:543444) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Fabino Life Sciences Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Fabino Life Sciences (BOM:543444) Business Description

Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines